Validating Differential Volatilome Profiles in Parkinson's Disease.

Area of Science:

• Biochemistry
• Analytical Chemistry
• Neuroscience

Background:

• Parkinson's disease (PD) lacks a definitive clinical diagnostic test.
• Nonmotor symptoms, including skin conditions and a distinct body odor, are increasingly recognized in PD.
• Previous research has identified a characteristic odor associated with Parkinson's disease patients.

Purpose of the Study:

• To directly measure and analyze volatile organic compounds (VOCs) in skin sebum from Parkinson's patients and controls.
• To establish a reliable analytical method for identifying a potential diagnostic biomarker for PD.
• To validate previous findings on differential volatile profiles in PD.

Main Methods:

• Dynamic headspace (DHS) thermal desorption (TD) coupled with gas chromatography-mass spectrometry (GC-MS) was employed.
• Sebum samples were collected from skin swabs of 100 PD patients (drug-naïve and medicated) and 29 controls.
• Supervised multivariate analyses were used to classify PD cases based on detected volatile compounds.

Main Results:

• The analytical method achieved 84.4% correct classification of PD cases using all detected volatile compounds.
• Eight key features with significant variable importance (VIP > 1, p < 0.05) were identified, showing downregulation in controls.
• Analysis suggested the presence of hydrocarbon species, potentially lipid breakdown products, rather than intact differentiated compounds.

Conclusions:

• A differential volatile profile in skin sebum can be reliably measured in Parkinson's disease patients using DHS-TD-GC-MS.
• This analytical approach holds promise for developing a non-invasive diagnostic biomarker for Parkinson's disease.
• The identified volatile compounds may represent novel biomarkers for early PD detection.